Luo Zhiying, Zheng Yi, Zhang Wei
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China,
Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, China,
Onco Targets Ther. 2018 Jul 18;11:4113-4124. doi: 10.2147/OTT.S151236. eCollection 2018.
MicroRNAs are short regulatory RNAs that posttranscriptionally modulate gene expression and thus play crucial roles in controlling cancer-onset, growth, and progression processes. miR107, a highly conserved microRNA that maps to intron 5 of the gene, contributes to the regulation of normal and tumor biological processes. Studies have reported that miR107 has oncogenic or tumor-suppressor functions in different human tumors. The pleiotropic functions of miR107 in various cancers are achieved via its targeting different genes that are involved in tumor proliferation, invasiveness, metastasis, angiogenesis, and chemotherapy-response pathways. The carcinogenicity or cancer-suppressor effects of miR107 occur in a tissue- and cell-specific manner, and the expression level of miR107 can be affected by various factors, including epigenetic and genetic factors, treatment exposure, and daily diet. A comprehensive analysis of the current literature suggests that miR107 functions as a central element in the regulation of cancer networks and can be used as a potential diagnostic and prognostic biomarker and drug target for therapeutic intervention.
微小RNA是短链调节性RNA,可在转录后调节基因表达,从而在控制癌症的发生、生长和进展过程中发挥关键作用。miR107是一种高度保守的微小RNA,定位于该基因的第5内含子,有助于调节正常和肿瘤生物学过程。研究报道,miR107在不同的人类肿瘤中具有致癌或抑癌功能。miR107在各种癌症中的多效性功能是通过靶向参与肿瘤增殖、侵袭、转移、血管生成和化疗反应途径的不同基因来实现的。miR107的致癌性或癌症抑制作用以组织和细胞特异性方式发生,并且miR107的表达水平可受到多种因素的影响,包括表观遗传和遗传因素、治疗暴露和日常饮食。对当前文献的综合分析表明,miR107在癌症网络调节中起核心作用,可作为潜在的诊断和预后生物标志物以及治疗干预的药物靶点。